News for Biotech Acquisition Company (BIOT)

Published at

Jan 24, 2025 1:14 PM

by insidermonkey.com

mixed

mixed

Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other diversified...

JNJ DJNJ3.BA DJNJ2.BA ABMD BIOTW BIOTU BIOT ITCI BRKBD.BA BRKBB.BA BRKB.BA

Read more →
Published at

Jan 14, 2025 5:20 PM

by investing.com

neutral

neutral

CERO stock touches 52-week low at $2.83 amid steep annual decline By Investing.com

CERO stock touches 52-week low at $2.83 amid steep annual decline

BIOTW BIOTU BIOT

Read more →
Published at

Dec 6, 2024 3:10 PM

by manilatimes.net

neutral

neutral

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

**media[485416]**

XENE NWE LWACW LWACU LWAC EFTR BIOTW BIOTU BIOT AMGN

Read more →
Published at

Oct 21, 2024 3:05 PM

by investing.com

positive

positive

CERo Therapeutics updates on clinical hold and management changes By Investing.com

CERo Therapeutics updates on clinical hold and management changes

BIOTW BIOTU BIOT

Read more →
Published at

Aug 7, 2024 8:54 PM

by investing.com

positive

positive

CERO stock plunges to 52-week low of $0.12 amid market challenges By Investing.com

CERO stock plunges to 52-week low of $0.12 amid market challenges

BIOTW BIOTU BIOT

Read more →
Published at

Jul 30, 2024 3:48 PM

by investing.com

neutral

neutral

CERO stock plunges to 52-week low of $0.17 amid market challenges By Investing.com

CERO stock plunges to 52-week low of $0.17 amid market challenges

BIOTW BIOTU BIOT

Read more →
Published at

Jul 29, 2024 11:24 PM

by investing.com

mixed

mixed

Earnings call: Revvity beats expectations even after a slight organic revenue dip By Investing.com

Earnings call: Revvity beats expectations even after a slight organic revenue dip

PKI GES EVR COWNL COWN BIOTW BIOTU BIOT BCS BAC AZN

Read more →
Published at

Jul 29, 2024 10:58 PM

by investing.com

mixed

mixed

Earnings call: Revvity's Q2 2024 earnings surpass expectations By Investing.com

Earnings call: Revvity's Q2 2024 earnings surpass expectations

PKI GES EVR COWNL COWN BIOTW BIOTU BIOT BCS BAC AZN

Read more →
Published at

Jul 26, 2024 11:23 PM

by investing.com

positive

positive

Cero Therapeutics faces FDA clinical hold on CER-1236 drug By Investing.com

Cero Therapeutics faces FDA clinical hold on CER-1236 drug

BIOTW BIOTU BIOT

Read more →
Published at

May 15, 2024 2:00 PM

by globenewswire.com

positive

positive

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy...

BIOTW BIOTU BIOT

Read more →
Published at

Apr 12, 2023 2:03 PM

by marketscreener.com

mixed

mixed

Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors

BOSTON, April 12, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific... | April 12, 2023

JNJ DJNJ3.BA DJNJ2.BA CUE BIOTW BIOTU BIOT MNTA

Read more →
Published at

Apr 12, 2023 2:00 PM

by globenewswire.com

mixed

mixed

Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...

JNJ DJNJ3.BA DJNJ2.BA CUE BIOTW BIOTU BIOT MNTA

Read more →
Published at

Apr 4, 2023 2:30 PM

by globenewswire.com

positive

positive

Bright Green Announces Decision to Complete Alterola Biotech Acquisition

Bright Green to acquire remaining 75% of Alterola common stock Agreements and completion will be subject to customary conditions and regulatory and...

BIOTW BIOTU BIOT ABTI

Read more →
Published at

Mar 3, 2023 1:13 PM

by investing.com

positive

positive

Oculis Announces Public Listing on NASDAQ By Investing.com

Oculis Announces Public Listing on NASDAQ

ISEE EBACU EBAC BIOTW BIOTU BIOT

Read more →
Published at

Mar 3, 2023 1:00 PM

by globenewswire.com

positive

positive

Oculis Announces US Public Listing on NASDAQ

Oculis Announces US Public Listing on NASDAQ Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology...

ISEE EBACU EBAC BIOTW BIOTU BIOT

Read more →
Published at

Oct 17, 2022 11:39 PM

by seekingalpha.com

positive

positive

SPAC European Biotech to merge with Swiss eye drug developer Oculis (NASDAQ:EBAC)

Dutch SPAC European Biotech Acquisition Corp. (EBAC) plans to merge with Swiss eye drug developer Oculis in a deal that estimates the enterprise value of the combined company at $220M.

EBACU EBAC BIOTW BIOTU BIOT

Read more →
Published at

Oct 17, 2022 4:03 PM

by marketscreener.com

positive

positive

European Biotech Acquisition : Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovation

Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology ... | October 17, 2022

EBACU EBAC BIOTW BIOTU BIOT

Read more →